世界の全身性炎症反応症候群治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Systemic Inflammatory Response Syndrome Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4929
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、105ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、全身性炎症反応症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（髄膜炎、尿路感染症（UTI）、肺炎、自己免疫疾患、その他）、用途別市場規模（病院・外来手術センター、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・全身性炎症反応症候群治療の市場動向
・企業の競争状況、市場シェア
・全身性炎症反応症候群治療の種類別市場規模と予測2016-2027（髄膜炎、尿路感染症（UTI）、肺炎、自己免疫疾患、その他）
・全身性炎症反応症候群治療の用途別市場規模と予測2016-2027（病院・外来手術センター、専門クリニック、その他）
・全身性炎症反応症候群治療の北米市場規模2016-2027（アメリカ、カナダ）
・全身性炎症反応症候群治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・全身性炎症反応症候群治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・全身性炎症反応症候群治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・全身性炎症反応症候群治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（CytoSorbents Corporation、RegeneRx Biopharmaceuticals、Endacea、Adrenomed AG、GlaxoSmithKline、Asahi Kasei、Cardinal Health、Smith & Nephew、ConvaTec、AstraZeneca、Orion Corporation、CHIESI Farmaceutici、Mylan）
・結論

Market Analysis and Insights: Global Systemic Inflammatory Response Syndrome Treatment Market
The global Systemic Inflammatory Response Syndrome Treatment market size is projected to reach US$ 11740 million by 2027, from US$ 8346.7 million in 2020, at a CAGR of 4.5% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Systemic Inflammatory Response Syndrome Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Systemic Inflammatory Response Syndrome Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Systemic Inflammatory Response Syndrome Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Systemic Inflammatory Response Syndrome Treatment market.

Global Systemic Inflammatory Response Syndrome Treatment Scope and Market Size
Systemic Inflammatory Response Syndrome Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Systemic Inflammatory Response Syndrome Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Meningitis
Urinary Tract Infection (UTI)
Pneumonia
Autoimmune Diseases
Others

Segment by Application
Hospital & Ambulatory Surgical Centers
Specialty Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
CytoSorbents Corporation
RegeneRx Biopharmaceuticals
Endacea
Adrenomed AG
GlaxoSmithKline
Asahi Kasei
Cardinal Health
Smith & Nephew
ConvaTec
AstraZeneca
Orion Corporation
CHIESI Farmaceutici
Mylan

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Systemic Inflammatory Response Syndrome Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Meningitis
1.2.3 Urinary Tract Infection (UTI)
1.2.4 Pneumonia
1.2.5 Autoimmune Diseases
1.2.6 Others
1.3 Market by Application
1.3.1 Global Systemic Inflammatory Response Syndrome Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital & Ambulatory Surgical Centers
1.3.3 Specialty Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Systemic Inflammatory Response Syndrome Treatment Market Perspective (2016-2027)
2.2 Systemic Inflammatory Response Syndrome Treatment Growth Trends by Regions
2.2.1 Systemic Inflammatory Response Syndrome Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Systemic Inflammatory Response Syndrome Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Systemic Inflammatory Response Syndrome Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Systemic Inflammatory Response Syndrome Treatment Industry Dynamic
2.3.1 Systemic Inflammatory Response Syndrome Treatment Market Trends
2.3.2 Systemic Inflammatory Response Syndrome Treatment Market Drivers
2.3.3 Systemic Inflammatory Response Syndrome Treatment Market Challenges
2.3.4 Systemic Inflammatory Response Syndrome Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Systemic Inflammatory Response Syndrome Treatment Players by Revenue
3.1.1 Global Top Systemic Inflammatory Response Syndrome Treatment Players by Revenue (2016-2021)
3.1.2 Global Systemic Inflammatory Response Syndrome Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Systemic Inflammatory Response Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Systemic Inflammatory Response Syndrome Treatment Revenue
3.4 Global Systemic Inflammatory Response Syndrome Treatment Market Concentration Ratio
3.4.1 Global Systemic Inflammatory Response Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Systemic Inflammatory Response Syndrome Treatment Revenue in 2020
3.5 Systemic Inflammatory Response Syndrome Treatment Key Players Head office and Area Served
3.6 Key Players Systemic Inflammatory Response Syndrome Treatment Product Solution and Service
3.7 Date of Enter into Systemic Inflammatory Response Syndrome Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Systemic Inflammatory Response Syndrome Treatment Breakdown Data by Type
4.1 Global Systemic Inflammatory Response Syndrome Treatment Historic Market Size by Type (2016-2021)
4.2 Global Systemic Inflammatory Response Syndrome Treatment Forecasted Market Size by Type (2022-2027)

5 Systemic Inflammatory Response Syndrome Treatment Breakdown Data by Application
5.1 Global Systemic Inflammatory Response Syndrome Treatment Historic Market Size by Application (2016-2021)
5.2 Global Systemic Inflammatory Response Syndrome Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Systemic Inflammatory Response Syndrome Treatment Market Size (2016-2027)
6.2 North America Systemic Inflammatory Response Syndrome Treatment Market Size by Type
6.2.1 North America Systemic Inflammatory Response Syndrome Treatment Market Size by Type (2016-2021)
6.2.2 North America Systemic Inflammatory Response Syndrome Treatment Market Size by Type (2022-2027)
6.2.3 North America Systemic Inflammatory Response Syndrome Treatment Market Size by Type (2016-2027)
6.3 North America Systemic Inflammatory Response Syndrome Treatment Market Size by Application
6.3.1 North America Systemic Inflammatory Response Syndrome Treatment Market Size by Application (2016-2021)
6.3.2 North America Systemic Inflammatory Response Syndrome Treatment Market Size by Application (2022-2027)
6.3.3 North America Systemic Inflammatory Response Syndrome Treatment Market Size by Application (2016-2027)
6.4 North America Systemic Inflammatory Response Syndrome Treatment Market Size by Country
6.4.1 North America Systemic Inflammatory Response Syndrome Treatment Market Size by Country (2016-2021)
6.4.2 North America Systemic Inflammatory Response Syndrome Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Systemic Inflammatory Response Syndrome Treatment Market Size (2016-2027)
7.2 Europe Systemic Inflammatory Response Syndrome Treatment Market Size by Type
7.2.1 Europe Systemic Inflammatory Response Syndrome Treatment Market Size by Type (2016-2021)
7.2.2 Europe Systemic Inflammatory Response Syndrome Treatment Market Size by Type (2022-2027)
7.2.3 Europe Systemic Inflammatory Response Syndrome Treatment Market Size by Type (2016-2027)
7.3 Europe Systemic Inflammatory Response Syndrome Treatment Market Size by Application
7.3.1 Europe Systemic Inflammatory Response Syndrome Treatment Market Size by Application (2016-2021)
7.3.2 Europe Systemic Inflammatory Response Syndrome Treatment Market Size by Application (2022-2027)
7.3.3 Europe Systemic Inflammatory Response Syndrome Treatment Market Size by Application (2016-2027)
7.4 Europe Systemic Inflammatory Response Syndrome Treatment Market Size by Country
7.4.1 Europe Systemic Inflammatory Response Syndrome Treatment Market Size by Country (2016-2021)
7.4.2 Europe Systemic Inflammatory Response Syndrome Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Systemic Inflammatory Response Syndrome Treatment Market Size (2016-2027)
8.2 Asia-Pacific Systemic Inflammatory Response Syndrome Treatment Market Size by Type
8.2.1 Asia-Pacific Systemic Inflammatory Response Syndrome Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Systemic Inflammatory Response Syndrome Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Systemic Inflammatory Response Syndrome Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Systemic Inflammatory Response Syndrome Treatment Market Size by Application
8.3.1 Asia-Pacific Systemic Inflammatory Response Syndrome Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Systemic Inflammatory Response Syndrome Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Systemic Inflammatory Response Syndrome Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Systemic Inflammatory Response Syndrome Treatment Market Size by Region
8.4.1 Asia-Pacific Systemic Inflammatory Response Syndrome Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Systemic Inflammatory Response Syndrome Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Systemic Inflammatory Response Syndrome Treatment Market Size (2016-2027)
9.2 Latin America Systemic Inflammatory Response Syndrome Treatment Market Size by Type
9.2.1 Latin America Systemic Inflammatory Response Syndrome Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Systemic Inflammatory Response Syndrome Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Systemic Inflammatory Response Syndrome Treatment Market Size by Type (2016-2027)
9.3 Latin America Systemic Inflammatory Response Syndrome Treatment Market Size by Application
9.3.1 Latin America Systemic Inflammatory Response Syndrome Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Systemic Inflammatory Response Syndrome Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Systemic Inflammatory Response Syndrome Treatment Market Size by Application (2016-2027)
9.4 Latin America Systemic Inflammatory Response Syndrome Treatment Market Size by Country
9.4.1 Latin America Systemic Inflammatory Response Syndrome Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Systemic Inflammatory Response Syndrome Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Systemic Inflammatory Response Syndrome Treatment Market Size (2016-2027)
10.2 Middle East & Africa Systemic Inflammatory Response Syndrome Treatment Market Size by Type
10.2.1 Middle East & Africa Systemic Inflammatory Response Syndrome Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Systemic Inflammatory Response Syndrome Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Systemic Inflammatory Response Syndrome Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Systemic Inflammatory Response Syndrome Treatment Market Size by Application
10.3.1 Middle East & Africa Systemic Inflammatory Response Syndrome Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Systemic Inflammatory Response Syndrome Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Systemic Inflammatory Response Syndrome Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Systemic Inflammatory Response Syndrome Treatment Market Size by Country
10.4.1 Middle East & Africa Systemic Inflammatory Response Syndrome Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Systemic Inflammatory Response Syndrome Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 CytoSorbents Corporation
11.1.1 CytoSorbents Corporation Company Details
11.1.2 CytoSorbents Corporation Business Overview
11.1.3 CytoSorbents Corporation Systemic Inflammatory Response Syndrome Treatment Introduction
11.1.4 CytoSorbents Corporation Revenue in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021)
11.1.5 CytoSorbents Corporation Recent Development
11.2 RegeneRx Biopharmaceuticals
11.2.1 RegeneRx Biopharmaceuticals Company Details
11.2.2 RegeneRx Biopharmaceuticals Business Overview
11.2.3 RegeneRx Biopharmaceuticals Systemic Inflammatory Response Syndrome Treatment Introduction
11.2.4 RegeneRx Biopharmaceuticals Revenue in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021)
11.2.5 RegeneRx Biopharmaceuticals Recent Development
11.3 Endacea
11.3.1 Endacea Company Details
11.3.2 Endacea Business Overview
11.3.3 Endacea Systemic Inflammatory Response Syndrome Treatment Introduction
11.3.4 Endacea Revenue in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021)
11.3.5 Endacea Recent Development
11.4 Adrenomed AG
11.4.1 Adrenomed AG Company Details
11.4.2 Adrenomed AG Business Overview
11.4.3 Adrenomed AG Systemic Inflammatory Response Syndrome Treatment Introduction
11.4.4 Adrenomed AG Revenue in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021)
11.4.5 Adrenomed AG Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Systemic Inflammatory Response Syndrome Treatment Introduction
11.5.4 GlaxoSmithKline Revenue in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 Asahi Kasei
11.6.1 Asahi Kasei Company Details
11.6.2 Asahi Kasei Business Overview
11.6.3 Asahi Kasei Systemic Inflammatory Response Syndrome Treatment Introduction
11.6.4 Asahi Kasei Revenue in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021)
11.6.5 Asahi Kasei Recent Development
11.7 Cardinal Health
11.7.1 Cardinal Health Company Details
11.7.2 Cardinal Health Business Overview
11.7.3 Cardinal Health Systemic Inflammatory Response Syndrome Treatment Introduction
11.7.4 Cardinal Health Revenue in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021)
11.7.5 Cardinal Health Recent Development
11.8 Smith & Nephew
11.8.1 Smith & Nephew Company Details
11.8.2 Smith & Nephew Business Overview
11.8.3 Smith & Nephew Systemic Inflammatory Response Syndrome Treatment Introduction
11.8.4 Smith & Nephew Revenue in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021)
11.8.5 Smith & Nephew Recent Development
11.9 ConvaTec
11.9.1 ConvaTec Company Details
11.9.2 ConvaTec Business Overview
11.9.3 ConvaTec Systemic Inflammatory Response Syndrome Treatment Introduction
11.9.4 ConvaTec Revenue in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021)
11.9.5 ConvaTec Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Details
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Systemic Inflammatory Response Syndrome Treatment Introduction
11.10.4 AstraZeneca Revenue in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021)
11.10.5 AstraZeneca Recent Development
11.11 Orion Corporation
11.11.1 Orion Corporation Company Details
11.11.2 Orion Corporation Business Overview
11.11.3 Orion Corporation Systemic Inflammatory Response Syndrome Treatment Introduction
11.11.4 Orion Corporation Revenue in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021)
11.11.5 Orion Corporation Recent Development
11.12 CHIESI Farmaceutici
11.12.1 CHIESI Farmaceutici Company Details
11.12.2 CHIESI Farmaceutici Business Overview
11.12.3 CHIESI Farmaceutici Systemic Inflammatory Response Syndrome Treatment Introduction
11.12.4 CHIESI Farmaceutici Revenue in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021)
11.12.5 CHIESI Farmaceutici Recent Development
11.13 Mylan
11.13.1 Mylan Company Details
11.13.2 Mylan Business Overview
11.13.3 Mylan Systemic Inflammatory Response Syndrome Treatment Introduction
11.13.4 Mylan Revenue in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021)
11.13.5 Mylan Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Systemic Inflammatory Response Syndrome Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Meningitis
Table 3. Key Players of Urinary Tract Infection (UTI)
Table 4. Key Players of Pneumonia
Table 5. Key Players of Autoimmune Diseases
Table 6. Key Players of Others
Table 7. Global Systemic Inflammatory Response Syndrome Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Systemic Inflammatory Response Syndrome Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Systemic Inflammatory Response Syndrome Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Systemic Inflammatory Response Syndrome Treatment Market Share by Regions (2016-2021)
Table 11. Global Systemic Inflammatory Response Syndrome Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Systemic Inflammatory Response Syndrome Treatment Market Share by Regions (2022-2027)
Table 13. Systemic Inflammatory Response Syndrome Treatment Market Trends
Table 14. Systemic Inflammatory Response Syndrome Treatment Market Drivers
Table 15. Systemic Inflammatory Response Syndrome Treatment Market Challenges
Table 16. Systemic Inflammatory Response Syndrome Treatment Market Restraints
Table 17. Global Systemic Inflammatory Response Syndrome Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Systemic Inflammatory Response Syndrome Treatment Market Share by Players (2016-2021)
Table 19. Global Top Systemic Inflammatory Response Syndrome Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Systemic Inflammatory Response Syndrome Treatment as of 2020)
Table 20. Ranking of Global Top Systemic Inflammatory Response Syndrome Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Systemic Inflammatory Response Syndrome Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Systemic Inflammatory Response Syndrome Treatment Product Solution and Service
Table 24. Date of Enter into Systemic Inflammatory Response Syndrome Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Systemic Inflammatory Response Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Systemic Inflammatory Response Syndrome Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Systemic Inflammatory Response Syndrome Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Systemic Inflammatory Response Syndrome Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Systemic Inflammatory Response Syndrome Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Systemic Inflammatory Response Syndrome Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Systemic Inflammatory Response Syndrome Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Systemic Inflammatory Response Syndrome Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Systemic Inflammatory Response Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Systemic Inflammatory Response Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Systemic Inflammatory Response Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Systemic Inflammatory Response Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Systemic Inflammatory Response Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Systemic Inflammatory Response Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Systemic Inflammatory Response Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Systemic Inflammatory Response Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Systemic Inflammatory Response Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Systemic Inflammatory Response Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Systemic Inflammatory Response Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Systemic Inflammatory Response Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Systemic Inflammatory Response Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Systemic Inflammatory Response Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Systemic Inflammatory Response Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Systemic Inflammatory Response Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Systemic Inflammatory Response Syndrome Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Systemic Inflammatory Response Syndrome Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Systemic Inflammatory Response Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Systemic Inflammatory Response Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Systemic Inflammatory Response Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Systemic Inflammatory Response Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Systemic Inflammatory Response Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Systemic Inflammatory Response Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Systemic Inflammatory Response Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Systemic Inflammatory Response Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Systemic Inflammatory Response Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Systemic Inflammatory Response Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Systemic Inflammatory Response Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Systemic Inflammatory Response Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. CytoSorbents Corporation Company Details
Table 65. CytoSorbents Corporation Business Overview
Table 66. CytoSorbents Corporation Systemic Inflammatory Response Syndrome Treatment Product
Table 67. CytoSorbents Corporation Revenue in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 68. CytoSorbents Corporation Recent Development
Table 69. RegeneRx Biopharmaceuticals Company Details
Table 70. RegeneRx Biopharmaceuticals Business Overview
Table 71. RegeneRx Biopharmaceuticals Systemic Inflammatory Response Syndrome Treatment Product
Table 72. RegeneRx Biopharmaceuticals Revenue in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 73. RegeneRx Biopharmaceuticals Recent Development
Table 74. Endacea Company Details
Table 75. Endacea Business Overview
Table 76. Endacea Systemic Inflammatory Response Syndrome Treatment Product
Table 77. Endacea Revenue in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 78. Endacea Recent Development
Table 79. Adrenomed AG Company Details
Table 80. Adrenomed AG Business Overview
Table 81. Adrenomed AG Systemic Inflammatory Response Syndrome Treatment Product
Table 82. Adrenomed AG Revenue in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 83. Adrenomed AG Recent Development
Table 84. GlaxoSmithKline Company Details
Table 85. GlaxoSmithKline Business Overview
Table 86. GlaxoSmithKline Systemic Inflammatory Response Syndrome Treatment Product
Table 87. GlaxoSmithKline Revenue in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 88. GlaxoSmithKline Recent Development
Table 89. Asahi Kasei Company Details
Table 90. Asahi Kasei Business Overview
Table 91. Asahi Kasei Systemic Inflammatory Response Syndrome Treatment Product
Table 92. Asahi Kasei Revenue in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 93. Asahi Kasei Recent Development
Table 94. Cardinal Health Company Details
Table 95. Cardinal Health Business Overview
Table 96. Cardinal Health Systemic Inflammatory Response Syndrome Treatment Product
Table 97. Cardinal Health Revenue in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 98. Cardinal Health Recent Development
Table 99. Smith & Nephew Company Details
Table 100. Smith & Nephew Business Overview
Table 101. Smith & Nephew Revenue in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 102. Smith & Nephew Recent Development
Table 103. ConvaTec Company Details
Table 104. ConvaTec Business Overview
Table 105. ConvaTec Systemic Inflammatory Response Syndrome Treatment Product
Table 106. ConvaTec Revenue in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 107. ConvaTec Recent Development
Table 108. AstraZeneca Company Details
Table 109. AstraZeneca Business Overview
Table 110. AstraZeneca Systemic Inflammatory Response Syndrome Treatment Product
Table 111. AstraZeneca Revenue in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 112. AstraZeneca Recent Development
Table 113. Orion Corporation Company Details
Table 114. Orion Corporation Business Overview
Table 115. Orion Corporation Systemic Inflammatory Response Syndrome Treatment Product
Table 116. Orion Corporation Revenue in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 117. Orion Corporation Recent Development
Table 118. CHIESI Farmaceutici Company Details
Table 119. CHIESI Farmaceutici Business Overview
Table 120. CHIESI Farmaceutici Systemic Inflammatory Response Syndrome Treatment Product
Table 121. CHIESI Farmaceutici Revenue in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 122. CHIESI Farmaceutici Recent Development
Table 123. Mylan Company Details
Table 124. Mylan Business Overview
Table 125. Mylan Systemic Inflammatory Response Syndrome Treatment Product
Table 126. Mylan Revenue in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 127. Mylan Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Systemic Inflammatory Response Syndrome Treatment Market Share by Type: 2020 VS 2027
Figure 2. Meningitis Features
Figure 3. Urinary Tract Infection (UTI) Features
Figure 4. Pneumonia Features
Figure 5. Autoimmune Diseases Features
Figure 6. Others Features
Figure 7. Global Systemic Inflammatory Response Syndrome Treatment Market Share by Application: 2020 VS 2027
Figure 8. Hospital & Ambulatory Surgical Centers Case Studies
Figure 9. Specialty Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Systemic Inflammatory Response Syndrome Treatment Report Years Considered
Figure 12. Global Systemic Inflammatory Response Syndrome Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Systemic Inflammatory Response Syndrome Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Systemic Inflammatory Response Syndrome Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Systemic Inflammatory Response Syndrome Treatment Market Share by Regions (2022-2027)
Figure 16. Global Systemic Inflammatory Response Syndrome Treatment Market Share by Players in 2020
Figure 17. Global Top Systemic Inflammatory Response Syndrome Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Systemic Inflammatory Response Syndrome Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Systemic Inflammatory Response Syndrome Treatment Revenue in 2020
Figure 19. Global Systemic Inflammatory Response Syndrome Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Systemic Inflammatory Response Syndrome Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Systemic Inflammatory Response Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Systemic Inflammatory Response Syndrome Treatment Market Share by Type (2016-2027)
Figure 23. North America Systemic Inflammatory Response Syndrome Treatment Market Share by Application (2016-2027)
Figure 24. North America Systemic Inflammatory Response Syndrome Treatment Market Share by Country (2016-2027)
Figure 25. United States Systemic Inflammatory Response Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Systemic Inflammatory Response Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Systemic Inflammatory Response Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Systemic Inflammatory Response Syndrome Treatment Market Share by Type (2016-2027)
Figure 29. Europe Systemic Inflammatory Response Syndrome Treatment Market Share by Application (2016-2027)
Figure 30. Europe Systemic Inflammatory Response Syndrome Treatment Market Share by Country (2016-2027)
Figure 31. Germany Systemic Inflammatory Response Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Systemic Inflammatory Response Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Systemic Inflammatory Response Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Systemic Inflammatory Response Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Systemic Inflammatory Response Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Systemic Inflammatory Response Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Systemic Inflammatory Response Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Systemic Inflammatory Response Syndrome Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Systemic Inflammatory Response Syndrome Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Systemic Inflammatory Response Syndrome Treatment Market Share by Region (2016-2027)
Figure 41. China Systemic Inflammatory Response Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Systemic Inflammatory Response Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Systemic Inflammatory Response Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Systemic Inflammatory Response Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Systemic Inflammatory Response Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Systemic Inflammatory Response Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Systemic Inflammatory Response Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Systemic Inflammatory Response Syndrome Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Systemic Inflammatory Response Syndrome Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Systemic Inflammatory Response Syndrome Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Systemic Inflammatory Response Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Systemic Inflammatory Response Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Systemic Inflammatory Response Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Systemic Inflammatory Response Syndrome Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Systemic Inflammatory Response Syndrome Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Systemic Inflammatory Response Syndrome Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Systemic Inflammatory Response Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Systemic Inflammatory Response Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Systemic Inflammatory Response Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. CytoSorbents Corporation Revenue Growth Rate in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021)
Figure 61. RegeneRx Biopharmaceuticals Revenue Growth Rate in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021)
Figure 62. Endacea Revenue Growth Rate in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021)
Figure 63. Adrenomed AG Revenue Growth Rate in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021)
Figure 64. GlaxoSmithKline Revenue Growth Rate in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021)
Figure 65. Asahi Kasei Revenue Growth Rate in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021)
Figure 66. Cardinal Health Revenue Growth Rate in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021)
Figure 67. Smith & Nephew Revenue Growth Rate in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021)
Figure 68. ConvaTec Revenue Growth Rate in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021)
Figure 69. AstraZeneca Revenue Growth Rate in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021)
Figure 70. Orion Corporation Revenue Growth Rate in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021)
Figure 71. CHIESI Farmaceutici Revenue Growth Rate in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021)
Figure 72. Mylan Revenue Growth Rate in Systemic Inflammatory Response Syndrome Treatment Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

以下、関連資料のご紹介

世界の全身性エリテマトーデス治療市場規模・現状・予測（2021年-2027年）

Global Systemic Lupus Erythematosus Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4930 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、全身性エリテマトーデス治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗マラリア薬、非ステロイド性抗炎症薬、コルチコステロイド、その他）、用途別市場規模（病院薬局、小売薬局、オンライン販売）、主要...

世界の全身性強皮症治療市場規模・現状・予測（2021年-2027年）

Global Systemic Scleroderma Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4931 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、全身性強皮症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（免疫抑制剤、ホスホジエステラーゼ5阻害剤-PHA、エンドセリン受容体拮抗薬、プロスタサイクリン類似体、カルシウムチャネル遮断薬、その他）...

世界の肝腎症候群治療市場規模・現状・予測（2021年-2027年）

Global Hepatorenal Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4305 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、肝腎症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ヘパトレン、テルリバズ、グリプレシン、ルカシン、その他）、用途別市場規模（1型肝腎症候群、2型肝腎症候群）、主要地域別市場規模（北米、アメ...

世界のレノックス・ガストー症候群治療市場規模・現状・予測（2021年-2027年）

Global Lennox-Gastaut Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4422 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、レノックス・ガストー症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非外科的治療、外科的治療）、用途別市場規模（発作、眼球異常、脳波所見、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界のダンピング症候群治療市場規模・現状・予測（2021年-2027年）

Global Dumping Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4163 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、ダンピング症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医療、外科療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド...

世界のグッドパスチャー症候群治療市場規模・現状・予測（2021年-2027年）

Global Goodpasture Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5758 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、グッドパスチャー症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、免疫抑制剤、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界のレット症候群治療市場規模・現状・予測（2021年-2027年）

Global Rett Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5994 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、レット症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗てんかん薬、抗てんかん薬、鎮静催眠薬、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

Global HIV Associated Lipodystrophy Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4315 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、HIV関連リポジストロフィー症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（特定薬剤治療、化粧品矯正治療）、用途別市場規模（病院、専門医クリニック、その他）、主要地域別市場規模（北米、アメリ...

世界のハンター症候群治療市場規模・現状・予測（2021年-2027年）

Global Hunter Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4334 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、ハンター症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（酵素補充療法（ERT）、造血幹細胞移植（HSCT）、その他）、用途別市場規模（ライフサイエンス企業、研究所、病院）、主要地域別市場規模...

世界のQT延長症候群治療市場規模・現状・予測（2021年-2027年）

Global Long QT Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4438 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、QT延長症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医療、外科治療）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界の全身性エリテマトーデス治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Systemic Lupus Erythematosus Treatment Market The global Systemic Lupus Erythematosus Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis a…
世界の全身性強皮症治療市場規模・現状・予測（2021年-2027年） Systemic scleroderma is an autoimmune disorder that affects the skin and internal organs . It is characterized by the buildup of scar tissue (fibrosis) in the skin and other organs. The fibrosis is caused by the body's production of too much collagen, which normally strengthens and supports connecti…
世界の上気道感染症治療市場規模・現状・予測（2021年-2027年） Rhinitis, sinusitis, nasopharyngitis, epiglottitis, laryngitis, and whooping cough are some of the types of upper respiratory tract infections. It can be treated with various drugs such as azithromycin, doxycycline, xylometazoline, propylhexedrine, amoxicillin, clarithromycin, aspirin, ibuprofen, er…
世界のダンピング症候群治療市場規模・現状・予測（2021年-2027年） Dumping syndrome is a condition which develops after the surgery done to lose weight by removing all or part of the stomach. It is also called rapid gastric emptying and dumping syndrome, occurs when food especially sugar moves from the stomach into the small bowel too quickly. In some cases dumping…
世界のレノックス・ガストー症候群治療市場規模・現状・予測（2021年-2027年） Lennox–Gastaut syndrome (LGS) is a complex, rare, and severe childhood-onset epilepsy. It is characterized by multiple and concurrent seizure types, cognitive dysfunction, and slow spike waves on electroencephalogram (EEG). Typically, it presents in children aged 3–5 years and can persist into adult…